Page 16 - ebook HCC

14 PROGRAMME AND ABSTRACTS GENEVA, SWITZERLAND EASL HCC SUMMIT 15
FEBRUARY 13 - 16, 2014

SCIENTIFIC PROGRAMME

THURSDAY, FEBRUARY 13, 2014 14:50 15:05 OPPOSING PPARG AND ROSIGLITAZONE PATHWAYS CONVERGE
ON RUVBL1 IN HCC CELL LINES
9:00-12:00 WORKING GROUP MEETING: MOLECULAR CLASSIFICATION 15:05 15:20 Tommaso Mello, Italy
BASIC PROGRAMME BASIC RESEARCH PROGRAMME 15:20 15:50 SENESCENCE BASIC PROGRAMME
OF HCC
NOTCH1 DRIVES SECRETOME SWITCHING IN RAS-INDUCED
Matthew Hoare, United Kingdom
Molecular Pathogenesis and Translational Research in Liver Cancer
CELL CYCLE, METABOLISM AND HCC
February 13 14, 2014 Geneva
COFFEE BREAK
15:50 16:20 Lluis Fajas, Switzerland
Organisers:
Michael Manns, Hannover, Germany 16:20 18:20 SESSION 3: TUMOUR STEM CELLS
Peter Schirmacher, Heidelberg, Germany Chair: Thomas Lüdde, Germany, Peter Galle, Germany
Jessica Zucman-Rossi, Paris, France 16:20 16:50 MIXED LIVER TUMOUR DIFFERENTIATION
Tania Roskams, Belgium
THURSDAY, FEBRUARY 13, 2014 16:50 17:20 PROFILING, CANCER STEM CELLS
Snorri Thorgeirsson, USA
12:15 WELCOME AND INTRODUCTION
Michael Manns, Germany 17:20 17:35 SPECIFIC TARGETING OF STEM-LIKE CELLS IN LIVER CANCER BY
Peter Schirmacher, Germany NF-KB MEDIATED INHIBITON OF HISTONE DEACETYLASES
Jens Marquardt, Germany
12:20 13:20 SESSION 1: HCC EPIDEMIOLOGY AND PREDISPOSITION
Chair: Michael Manns, Germany, Ansgar Lohse, Germany 17:35 17:50 SIDE POPULATION ANALYSIS IDENTIFIES A ROLE FOR LAMININ IN
MODULATING THE HUMAN HEPATIC CANCER STEM CELL NICHE
12:20 12:50 GENETIC PREDISPOSITION TO HCC
Pierre Nahon, France Olivier Govaere, Belgium
17:50 18:05 RAGE SIGNALING IN OVAL CELL ACTIVATION DURING
12:50 13:20 POLYPLOIDY
Chantal Desdouet, France LIVER DAMAGE
Aurora De Ponti, Germany
13:20 13:50 COFFEE BREAK
18:05 - 18:20 RESECTABLE TRANSGENIC TUMOUR MODEL IN MICE FOR
13:50 15:50 SESSION 2: METABOLIC AND ENDOCRINE MECHANISMS INTRAHEPATIC CHOLANGIOCARCINOMA
Chair: Nisar Malek, Germany, Tania Roskams, Belgium Engin Gürlevik, Germany
13:50 14:20 METABOLIC MECHANISMS 18:30 COCKTAIL RECEPTION FOR ALL PARTICIPANTS AND POSTER
Stephan Herzig, Germany SESSION
14:20 14:50 ENDOCRINE HEPATOCARCINOGENESIS
Frank Dombrowski, Germany